NORADRENALIN Nardia 16 mg/250ml sol perf

7680703260036 CH-70326 C01CA03 02.05.2.

No images available

Details

Product number
7032603
CPT
-
Packaging group
10 x 250 ml
Unit
Beutel
Composition
noradrenalinum 0.064 mg ut noradrenalini tartras, natrii chloridum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 3.5 mg.

Articles (1)

Noradrenalin Nardia 0,064 mg/ml, soluzione per infusione
soluzione
10 x 250 ml
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
27/08/2026
Professional SmPC
Français
27/08/2026
Professional SmPC
Italien
27/08/2026

Detailed composition

Substance Quantity Type Category
noradrenalinum
0.064 MG Substance Wirkstoff (Principe actif)
noradrenalini tartras
- Substance WIZUS
natrii chloridum
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
3.5 MG Substance HBESI

Authorization holder

Nardia Pharmaceuticals SA

6855 Stabio

Authorization information

Swissmedic authorization number
70326
Drug name
Noradrenalin Nardia, soluzione per infusione
Galenic form
LSINF
ATC Code
C01CA03
Authorization status
Z
Dispensation category
B
First authorization
06/07/2026
Authorization expiration date
05/07/2031
IT number
02.05.2.
Domain
Human medicine

Packaging details

Description (FR)
NORADRENALIN Nardia 16 mg/250ml sol perf
Description (DE)
NORADRENALIN Nardia 16 mg/250ml Inf Lös
Market launch
01/12/2026
Narcotic (BTM)
No

Other packaging sizes

NORADRENALIN Nardia 4 mg/250ml sol perf
10 x 250 ml BEU
View
NORADRENALIN Nardia 8 mg/250ml sol perf
10 x 250 ml BEU
View
Buy us a coffee Explore the data